Introduction
Preterm birth is one of the leading causes for neonatal mortality and morbidity worldwide and accounts for 75% of neonatal deaths and more than 50% of long-term neurological impairment in children. 1 The major determinant of severity is gestational age. Especially children born before 34 weeks of gestation are at increased risk to develop respiratory distress syndrome, developmental delay, cerebral palsy and other chronic disorders. 2 Periventricular leucomalacia (PVL) is a major perinatal complication in preterm infants. More than 70% of preterm infants with PVL later develop cerebral palsy and/or cognitive deficits. 3 The pathophysiological mechanisms leading to preterm birth and the development of PVL in preterm infants remain poorly understood and are thought to be mutifactorial. 4, 5 Emerging clinical and experimental evidence suggests a critical role of inflammation and inflammatory mediators in the pathophysiology of both, preterm birth and perinatal brain injury. The main hypothesis is that bacteria ascend from the vagina through the chorioamniotic membranes into the amniotic fluid and eventually gain access to the fetus. The microbial invasion activates a cascade of cytokines and chemokines and evokes a fetal inflammatory response syndrome, which causes rupture of the membranes and injury to the lung and central nervous system in the fetal compartment. 6, 7 Various studies showed an association between intrauterine infection of the placenta and preterm birth as well as neonatal neurological disorders. 8, 9 In preterm infants, increased concentrations of several pro-and antiinflammatory cytokines in blood or amniotic fluid are associated with abnormal cranial ultrasound appearances consistent with PVL and later impairment of neurodevelopmental outcome. 10 The pro-inflammatory cytokine tumor necrosis factor-a (TNF-a) seems to have a central role in preterm delivery especially in those associated with infections. 11 The impact of TNF-a on the pathophysiology of brain injury remains poorly understood even though a dual role of this cytokine was hypothesized. 12 Several studies show a deleterious effect of increased TNF-a expression on the fetal brain 13, 14 whereas others provide evidence that TNF-a has a critical role in facilitating the recovery after brain injury. 15 The antiinflammatory interleukin (IL)-10 cytokine inhibits pro-inflammatory cytokines and chemokines. 16 Furthermore IL-10 has been shown to have neuroprotective effects following hypoxia-ischemia. 17 For various human cytokine genes single nucleotide polymorphisms (SNP) have been described. Such polymorphisms for TNF-a and IL-10 are located within regulatory regions leading to increased or decreased production of the corresponding cytokine in response to various stimuli and thus may affect illness severity during infections. [18] [19] [20] Due to inconsistent studies the question was raised whether or not there is an association between certain functional SNPs in the TNF-a and IL-10 genes and preterm birth in the presence or absence of PVL. Here we investigate the distribution of TNF-a (À308), IL-10 (À1082) and IL-10 (À819) genotypes of mother/child pairs with delivery at term and compare them to those with preterm delivery and with children who developed PVL in the perinatal period.
The cytokines TNF-a and IL-10 were tested because of their association with intrauterine infection and fetal brain injury. 17, 21 
Methods

Study population
This study was approved by the Ethical Committee of the Medical Faculty of the Medical University of Graz, Austria. Subjects were recruited at the Department of Obstetrics and Gynaecology and the Department of Pediatrics of the Medical University of Graz upon admission to the hospital. Pregnant women from 18 to 45 years of age were invited to participate in the study and informed consent was obtained from all participants. Gestational age was determined by the last menstrual period and corroborated by ultrasound dating. A total of 306 mother/child pairs and seven children were included in the study and divided into the preterm delivery group, the term delivery group (with delivery before or after 37 weeks of gestation, respectively) and the PVL group with children who developed PVL after preterm delivery.
Exclusion criteria comprised multiple pregnancies, preeclampsia, chronic infection diseases, such as hepatitis B/C or HIV infection, uterine malformation, previous uterine surgery, placental abruption, placental insufficiency, placenta previa, umbilical cord prolapse, intrauterine growth restriction, congenital abnormalities of the child (except PVL) and in vitro fertilization. Venous blood samples were collected from mothers. Buccal swabs and/or cord blood samples were collected from newborns.
Extraction of maternal and infant DNA for genotyping of SNPs Genomic DNA was extracted from maternal venous blood samples and cord blood using the InstaGene Matrix (Bio-Rad Laboratories, Vienna, Austria) according to manufacturers instructions. Genomic DNA from buccal swabs was extracted using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the buccal swab spin protocol provided by the manufacturers.
Analysis of IL-10 (À1082), IL-10 (À819) and TNF-a (À308) polymorphisms IL-10 and TNF-a polymorphisms were determined with allele specific PCR. For a detailed description and primers used see Supplementary Information at the Journal's website.
Statistical analysis
Statistical analysis of patients' characteristics was tested with analysis of variance or Kruskal-Wallis tests with post hoc tests, as appropriate. Correlations between maternal and infantile polymorphisms were calculated using w 2 -tests or Fisher's exact test, as appropriate. Cramer-V was determined indicating the strength of correlations. Calculations were performed with the SPSS statistical software package (SPSS, version 17, Chicago, IL, USA). P-values p0.05 were considered significant.
Results
Characterization of the study population
In this study a total of 306 mother/child pairs and seven children were included and divided into three groups representing (a) term deliveries, (b) preterm deliveries and (c) preterm deliveries with PVL in the newborns. Spontaneous vaginal deliveries as well as elective and emergency cesarean sections were included in the study (Table 1) . Maternal and infant characteristics are Genetic polymorphisms and preterm birth M Nuk et al summarized in Table 1 . The maternal age did not significantly differ between the three groups (P ¼ 0.063). The median birth weight of preterm children with or without PVL was significantly lower compared with children born at term (P<0.001) without any differences between the two preterm groups. Apgar scores determined 1, 5 and 10 min after delivery differed significantly between term versus preterm infants and term versus PVL infants with no significant differences between the two preterm groups.
IL-10 (À819) and IL-10 (À1082) genotypes in mother/child pairs of term and preterm deliveries IL-10 (À819) was determined in mother/child pairs of children born at term or preterm ( Table 2 ). In mothers and children the distribution of IL-10 (À819) genotypes did not differ between term and preterm deliveries (P ¼ 0.67 and P ¼ 0.55, respectively) ( Table 2) . IL-10 (À1082) genotypes were similarly distributed in mothers delivering at term or preterm in the presence and absence of neonatal PVL showing no significant difference among these three groups (P ¼ 0.14). IL-10 (À1082) genotype distribution of infants indicated a slight increase of the IL-10 (À1082) AA genotype in the preterm delivery groups with or without PVL (40% and 44%, respectively) compared with the term delivery group (27%). However, the difference was too weak to reach statistical significance (P ¼ 0.12) ( Table 2) .
TNF-a (À308) genotypes in mother/child pairs of term and preterm deliveries The distribution of TNF-a (À308) genotypes in mothers showed no significant difference among the three groups (P ¼ 0.85). TNF-a (À308) genotype distribution of infants indicated a slight but not significant increase of TNF-a (À308) AA genotype in the preterm delivery groups with or without PVL (3% and 6%, respectively) compared with the term delivery group (1%) (P ¼ 0.08) ( Table 2) .
Correlation between IL-10 (À819) and IL-10 (À1082) polymorphisms When the distribution of all genotypes was compared between TNF-a, IL-10 (À819) and IL-10 (À1082) regardless of the Genetic polymorphisms and preterm birth M Nuk et al gestational age at delivery, no correlation was found between TNF-a and any of the two IL-10 variants neither in mothers nor in children (data not shown). Interestingly, in both groups a significant correlation of the IL-10 (À819) polymorphisms with the IL-10 (À1082) polymorphisms was found (Cramer-V <0.001; P<0.001). Fetal as well as maternal DNA revealed that the TT genotype of IL-10 (À819) occurs mainly in combination with the AA genotype of IL-10 (À1082). Besides, the GG genotype of IL-10 (À1082) seems to be mainly present in combination with the CC genotype of IL-10 (À819) ( Table 3) . Restriction of the preterm delivery group to very preterm deliveries only (before 34 weeks of gestation) as well as restriction to mother/child pairs with male fetuses did not lead to different results in any of the tested variables.
Discussion
During the time of gestation, a well-balanced and dynamic network of a variety of immunoregulators is critical to prepare the maternal and fetal organisms for physiological changes. At the time of parturition, the cytokine network is significantly involved in cervical ripening, promotion of fetal membrane weakening and rupture and may enhance myometrial muscle excitability and contractility. 22 Although the human cytokine system is well protected against many kinds of influences through redundancy of pathways and key factors, an imbalance between pro-and anti-inflammatory immunoregulators might lead to dramatic consequences. Elevated levels of the pro-inflammatory cytokine TNF-a and decreased levels of the anti-inflammatory cytokine IL-10 were shown to have a central role in the pathogenesis of preterm birth. 4 However, inconsistent results motivated us to investigate the distribution of IL-10 (À1082), IL-10 (À819) and TNF-a (À308) genotypes in mother/child pairs of term and preterm deliveries and of premature newborns who developed PVL.
In our study no statistically significant association for the IL-10 (À819) and (À1082) polymorphisms could be observed in mothers or in infants of term and preterm deliveries, which is in good agreement with some previous studies. 23, 24 In contrast to our results an association of the maternal IL-10 (À1082) AG and GG genotypes with deliveries before 35 weeks of gestation and of the IL-10 (À819) CC genotype in deliveries before 29 weeks of gestation has been reported. 25 When analyzing the TNF-a (À308) polymorphism we found no statistically significant difference of the genotype distribution in mothers or in infants with term deliveries compared with preterm deliveries reflecting the outcome of some previous studies. 23, 26 In contrast, two other studies found an association between the TNF-a (À308) polymorphism and preterm delivery. 27, 28 Inconsistent findings suggest that there are additional factors influencing the effect of TNF-a (À308) polymorphism on pregnancy outcomes. This hypothesis is supported by the results of a study reporting no correlation of the TNF-a mutant allele with idiopathic preterm birth, whereas a significant correlation was found for preterm births resulting from preterm premature rupture of the membranes. 29 Furthermore we investigated the prevalence of allelic variants in the TNF-a (À308) and the IL-10 (À1082) promoter regions regarding the development of PVL in premature infants. The role of IL-10 in the development of PVL is not known yet and to our knowledge, this is the first study paying attention to IL-10 (À1082) genotypes of mothers whose premature newborns developed PVL. Exogenously administered IL-10 shows a protective effect in animal models of ischemic brain injuries. 30, 31 Hence a neuroprotective role for IL-10 in the central nervous system is suggested. Increased concentrations of IL-10 were determined in cerebrospinal fluid of preborn infants with white matter injury compared with preborn children without such injury. 32 In a previous study the role of the IL-10 (À1082) SNP on the outcome in ventilated very low birthweight infants was investigated and no effect on the incidence or severity of intraventricular-periventricular hemorrhage or PVL was observed regarding this polymorphism. 33 In contrast, another group investigated the impact of the IL-10 (À1082) alleles on the risk for neonate disorders and found that infants with a gestational age of <32 weeks and homozygosity for the G allele were significantly less likely to develop ultrasound defined periventricular echodensities. 34 In our study no significant difference of IL-10 (À1082) genotypes in children who developed PVL was observed when compared with healthy children born at term or preterm.
TNF-a as a pro-inflammatory cytokine seems to be a key factor in brain injury. Although the expression of TNF-a during normal brain development is continually increasing during the late fetal period, overproduction of TNF-a by microglial cells was found to Genetic polymorphisms and preterm birth M Nuk et al be associated with the pathogenesis of neonatal leukomalacia. 35 Increased levels of TNF-a in cerebrospinal fluid of premature infants and neonate brains were associated with a higher occurrence of white matter damage, PVL or posthaemorrhagic ventricular dilatation. 36 Even in sample material remote from the spot of injury, including amniotic fluid, umbilical cord blood and neonatal blood, elevated levels of TNF-a were associated with an increased risk for the development of PVL. 37 In our study no significant association between maternal or infant TNF-a (À308) genotypes and the development of PVL in preterm children was observed. These findings are supported by other studies although the mutant A allele was reported to be associated with an increased risk for the development of intraventricular periventricular hemorrhage. 38, 39 We only found a weak, nonsignificant trend for the infant genotype of the TNF-a promoter region with a slightly increased frequency of the AA genotype in preterm infants with PVL compared with healthy term deliveries. However, as the total number of TNF-a (À308) AA genotype individuals was very low, a greater number of tested children may be necessary to confirm this trend.
Our data suggest that none of the tested cytokine polymorphisms may contribute to the prediction of preterm birth in the presence and absence of PVL. Further testing of a greater number of infants could serve to confirm the trend of homozygous TNF-a (À308) for the A allele in the PVL group compared with term deliveries. However, as the latter polymorphism occurs with such a low incidence, a predictive use remains doubtful, even if the distribution within the three groups might be significantly altered. The correlation of certain SNPs of IL-10 only was an additional finding in our study. The clinical relevance of this result remains unknown and needs to be further elucidated.
